Meeting details
Date of meeting:
Wednesday 13 September 2023
Time of meeting:
11am to 1pm
Meeting format:
MS Teams meeting
Members Present:
Dr Deirdre Mulholland (DM, Chair), Ms Mary Hewson (MH), Mr Damian Nee (DN), Prof Fergus O’Kelly (FO’K), Ms Margaret Brennan (MB)
Apologies:
Dr Alissa Connors (AC), Dr Caroline Mason Mohan (CMM), Ms Lorraine Schwanberg (LS), Dr Jennifer Martin (JM), Ms Suzanne Lynch (SL), Ms Grainne Gleeson (GG), Ms Hilary Coffey (HC), Ms Helen Kavanagh (HK)
In attendance:
Dr Noirin Russell (NR), Ms Colette Brett (CB), Ms Mary Sheedy (MS), Mr Declan O’Reilly (DoR), Ms Belinda Carroll (BC), Ms Catherine Hogan (CH), Ms Fiona Ness (FN), Ms Julie Keegan (JK), MR Stephen O’Brien (SoB), Ms Karolina Guzek (minutes).
Meeting minutes
1. Welcome, Introduction and Apologies
The Chair welcomed all members and thanked them for attending the meeting.
Apologies were noted.
2. Conflict of Interest
There was no conflict of interest to be noted.
Action: Noted
3. Minutes of Meeting 7th June 2023
Minutes of the previous meeting were reviewed. Request to remove the abbreviations and amended minutes to be send for Chair’s approval.
All members in agreement for revised Q2 2023 meeting minutes to be published online.
Action: Noted
4. NSS Quality, Safety & Risk (QSR) Information Report
NSS Quality, Safety and Risk Review Q2, 2023
- 2023 Q2 report presented and acknowledged.
NSS Corporate Risk Register Report Q2, 2023
- 2023 Q2 report presented and acknowledged.
Quality, Safety and Risk Dashboard Report Q2, 2023
- 2023 Q2 Dashboard reviewed and acknowledged.
Terms of Reference
- Draft Terms of Reference was reviewed, and minor changes suggested. List of members and attendees to be separated from the document and to be kept in QSRM Department and available on request.
- Action 49: Committee’s priorities for 2024 to be included on Q4 meeting agenda for discussion.
- Action 50: CB to email Committee members seeking volunteer for the QSRM Committee Chair’s deputy function.
Action: Noted
5. Cross-Programme Review
BreastCheck Programme Review Q2, 2023
- Report reviewed and acknowledged.
CervicalCheck Programme Review Q2, 2023
- Report reviewed and acknowledged.
BowelScreen Programme Review Q2, 2023
- Report reviewed and acknowledged.
DiabeticRetina Screen (DRS) Programme Review Q2, 2023
- Report reviewed and acknowledged.
- Comment regarding results being forwarded to client’s General Practitioner (GP) only was acknowledged by DRS Deputy Programme Manager and will be brought to the DRS attention as operational.
- Frequency of the Quality Assurance Committee meetings was re-considered, and quarterly meetings approved by Members. If required, frequency of the meetings to be reviewed when new Committee chair in post.
Action: Noted
6. NSS Stakeholders Update
The National Screening Service stakeholders’ updates were shared for noting.
International Agency for Research on Cancer Best Practice in Cervical Screening Programmes Report was shared for noting.
Action: Noted
7. Interval Cancer Steering Committee Update
Q2, 2023 Interval Cancer Project Update was shared for noting. Close-out report for the project is scheduled to be completed by end of Q4 2023 and will be shared with the Members for noting.
Action: Noted
8. Communications update
Quarterly Communications update presented to the Committee by FN. Focus on engagement and proactive communication, to include campaigns, briefings, media monitoring and openness and transparency with all NSS stakeholders was highlighted. New HSE Communication Strategy 2023-2025 is being applied across NSS with several communications projects open and progressing well under the Engagement and Partnership pillar of the NSS corporate strategy, Choose Screening. Members were encouraged to forward any items for further discussion to QSRM team and to be included on Q4 meeting agenda.
Action 47: Presentation slides to be circulated to Committee members.
Action 51: Quality, Safety and Risk team to follow up with DN regarding link to the Clevland Medical Clinic online article for sharing with Committee members.
Action: Noted
9. Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023
Multidisciplinary HSE Patient Safety Act Implementation Group in place with working subgroups. NSS chairing the Subgroup for Implementation of Part 5 reviews. Engagement is ongoing between the Department of Health and the HSE regarding clarity on some aspects of Patient Safety Act 2023.
Action: Noted
10. Actions Update
All actions reviewed and updated on the Action Log.
Request for the glossary to be added and to be mindful of abbreviations to be used going forward.
11. Any Other Business
No other business discussed.
Action: Noted
12. Date of next meeting
Next meeting scheduled for Monday, 11th December.
Poll to be conducted closer to date to assess whether in-person meeting feasible.
Action: Noted